Singapore has authorised the use of the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15 years as the country tackles a recent increase of infections.
"The data showed that the Pfizer-BioNTech COVID-19 vaccine demonstrated high efficacy consistent with that observed in the adult population," the health ministry said in a statement, adding, "its safety profile is also consistent with the known safety profile in the adult population."
The government will also extend the interval between two-dose COVID-19 vaccines to six to eight weeks, from three to four weeks currently, it said.
Saudi Arabia says shrapnel from intercepted ballistic missile in Asir injures one
Nine injured in Australia as car crashes into crowd north of Sydney
India's 'cockroach' youth party to protest, demand poll chief's resignation
Congo's Ebola outbreak has killed more than 4,000, government data shows
About 400 French schools closed as some student protests turn violent
